Apontis Pharma AG (APPH) — Capital Reinvestment Ratio
Apontis Pharma AG (APPH) has a Capital Reinvestment Ratio of 0.01x as of December 2024, meaning it reinvests 0% of its operating cash flow (€905.24K) in capital expenditures (€5.60K). Check APPH tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Apontis Pharma AG Capital Reinvestment Ratio (2020–2022)
This chart tracks Apontis Pharma AG's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see APPH cash generation efficiency.
Annual Capital Reinvestment Ratio for Apontis Pharma AG (2020–2022)
Year-by-year Capital Reinvestment Ratio for Apontis Pharma AG from 2020 to 2022. See how much free cash does Apontis Pharma AG generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.30x | €11.02 Million | €3.28 Million | ▼ -38.5% |
| 2021 | 0.48x | €3.43 Million | €1.66 Million | ▼ -3.8% |
| 2020 | 0.50x | €1.45 Million | €729.56K | — |